Novartis India Ltd — Dividend/Bonus, 10-05-2025: Corp. Action

Novartis India Limited has announced a board meeting on which approved the audited financial results for the quarter and financial year ended March 31, 2025. The company reported revenue from operations of ₹3562.7 million for the year, with a profit before tax of ₹1304.2 million and a net profit of ₹1009.0 million. The Board has proposed a final dividend of ₹25 per share (face value ₹5 each), subject to shareholder approval. Mr. Sanker Parameswaran has been approved for re-appointment as an Independent Non-Executive Director for five years, pending shareholder consent. Additionally, M K Saraf & Associates LLP has been appointed as Secretarial Auditors for five years, subject to shareholder approval. The company will conduct a postal ballot for Mr. Parameswaran’s re-appointment and a related party transaction with Novartis Pharma AG.